Works on the central nervous system not the vascular system to increase desire and arousal from the brain down
Several DPP-4 inhibitors with distinct structures have been approved for clinical use, including sitagliptin, alogliptin, linagliptin, gemigliptin, anagliptin, and teneligliptin (22) (Appendix 1 in Supplementary File)
Carbs and fats are adjusted around preference, training, digestion, and adherence
Phase 3 TRIUMPH program initiated May 2023
Through this exploration, we will uncover the nuances of managing complex health conditions in the modern medical landscape, emphasizing the importance of a holistic, patient-centered approach